Cargando…

Essential services: Quantifying the contributions of America’s pharmacists in COVID-19 clinical interventions

BACKGROUND: As the COVID-19 pandemic spread across the United States, America’s pharmacists and their teammates expanded their clinical services to help their communities from every practice setting: community and ambulatory care, inpatient, long-term care, academia, public health, and many others....

Descripción completa

Detalles Bibliográficos
Autor principal: Grabenstein, John D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Pharmacists Association®. Published by Elsevier Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9387064/
https://www.ncbi.nlm.nih.gov/pubmed/36202712
http://dx.doi.org/10.1016/j.japh.2022.08.010
_version_ 1784769945635127296
author Grabenstein, John D.
author_facet Grabenstein, John D.
author_sort Grabenstein, John D.
collection PubMed
description BACKGROUND: As the COVID-19 pandemic spread across the United States, America’s pharmacists and their teammates expanded their clinical services to help their communities from every practice setting: community and ambulatory care, inpatient, long-term care, academia, public health, and many others. OBJECTIVES: The objective of the study is to begin to quantify contributions of U.S. pharmacists in providing clinical interventions that mitigate and control the pandemic. These interventions span the gamut of diagnosis, prevention, treatment, and support, intervening patient by patient with vaccines, diagnostic tests, convalescent plasma, monoclonal antibodies, antiviral medications, and supportive therapies. METHODS: Review of published literature, relevant web pages, and queries to national and state professional pharmacy associations and government agencies. RESULTS: From February 2020 through September 2022, pharmacists and their teammates conducted >42 million COVID-19 tests, provided >270 million vaccinations (including 8.1 million COVID-19 vaccinations for long-term care residents) within community pharmacy programs alone, and provided >50 million influenza and other vaccinations per year. Pharmacists plausibly accounted for >50% of COVID-19 vaccinations in the United States. Pharmacists prescribed, dispensed, and administered an uncounted number of antibody products and antiviral medications, including care for 5.4 million inpatients and innumerable outpatients. Using conservative estimates, pandemic interventions by pharmacists and teammates averted >1 million deaths, >8 million hospitalizations, and $450 billion in health care costs. CONCLUSIONS: Pharmacists and their teammates contributed to America’s health and recovery during the COVID-19 pandemic by providing >350 million clinical interventions to >150 million people in the form of testing, parenteral antibodies, vaccinations, antiviral therapies, and inpatient care. The number of lives touched and people cared for by pharmacists continues to rise.
format Online
Article
Text
id pubmed-9387064
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Pharmacists Association®. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-93870642022-08-18 Essential services: Quantifying the contributions of America’s pharmacists in COVID-19 clinical interventions Grabenstein, John D. J Am Pharm Assoc (2003) Feature BACKGROUND: As the COVID-19 pandemic spread across the United States, America’s pharmacists and their teammates expanded their clinical services to help their communities from every practice setting: community and ambulatory care, inpatient, long-term care, academia, public health, and many others. OBJECTIVES: The objective of the study is to begin to quantify contributions of U.S. pharmacists in providing clinical interventions that mitigate and control the pandemic. These interventions span the gamut of diagnosis, prevention, treatment, and support, intervening patient by patient with vaccines, diagnostic tests, convalescent plasma, monoclonal antibodies, antiviral medications, and supportive therapies. METHODS: Review of published literature, relevant web pages, and queries to national and state professional pharmacy associations and government agencies. RESULTS: From February 2020 through September 2022, pharmacists and their teammates conducted >42 million COVID-19 tests, provided >270 million vaccinations (including 8.1 million COVID-19 vaccinations for long-term care residents) within community pharmacy programs alone, and provided >50 million influenza and other vaccinations per year. Pharmacists plausibly accounted for >50% of COVID-19 vaccinations in the United States. Pharmacists prescribed, dispensed, and administered an uncounted number of antibody products and antiviral medications, including care for 5.4 million inpatients and innumerable outpatients. Using conservative estimates, pandemic interventions by pharmacists and teammates averted >1 million deaths, >8 million hospitalizations, and $450 billion in health care costs. CONCLUSIONS: Pharmacists and their teammates contributed to America’s health and recovery during the COVID-19 pandemic by providing >350 million clinical interventions to >150 million people in the form of testing, parenteral antibodies, vaccinations, antiviral therapies, and inpatient care. The number of lives touched and people cared for by pharmacists continues to rise. American Pharmacists Association®. Published by Elsevier Inc. 2022 2022-08-18 /pmc/articles/PMC9387064/ /pubmed/36202712 http://dx.doi.org/10.1016/j.japh.2022.08.010 Text en © 2022 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Feature
Grabenstein, John D.
Essential services: Quantifying the contributions of America’s pharmacists in COVID-19 clinical interventions
title Essential services: Quantifying the contributions of America’s pharmacists in COVID-19 clinical interventions
title_full Essential services: Quantifying the contributions of America’s pharmacists in COVID-19 clinical interventions
title_fullStr Essential services: Quantifying the contributions of America’s pharmacists in COVID-19 clinical interventions
title_full_unstemmed Essential services: Quantifying the contributions of America’s pharmacists in COVID-19 clinical interventions
title_short Essential services: Quantifying the contributions of America’s pharmacists in COVID-19 clinical interventions
title_sort essential services: quantifying the contributions of america’s pharmacists in covid-19 clinical interventions
topic Feature
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9387064/
https://www.ncbi.nlm.nih.gov/pubmed/36202712
http://dx.doi.org/10.1016/j.japh.2022.08.010
work_keys_str_mv AT grabensteinjohnd essentialservicesquantifyingthecontributionsofamericaspharmacistsincovid19clinicalinterventions